Skip to main content
. 2022 Dec 15;16:1490. doi: 10.3332/ecancer.2022.1490

Table 1. Patients’ characteristics.

Number of patients Percentage %
Gender
Male
Female

33
28

54.1
45.9
Age
Median (range) years

53 (27–75)
Primary tumour side
Right
Left

7
54

11.5
88.5
Organ
Colon
Rectosigmoid
Rectum

21
22
18

34.4
36.1
29.5
Line of cetuximab based therapy
First line
Second line

33
28

54.1
45.9
Chemotherapy regimen
XELOX
XELIRI

26
35

42.6
57.4
Line of therapy and regimen
First-line XELOX
First-line XELIRI
Second-line XELOX
Second-line XELIRI

19
14
7
21

31.1
23
11.5
34.4